<DOC>
	<DOCNO>NCT00065650</DOCNO>
	<brief_summary>The purpose study determine feasibility effectiveness multimodality Vedic Medicine treatment protocol management newly diagnose type 2 diabetes .</brief_summary>
	<brief_title>Pilot Study Vedic Medicine Type 2 Diabetes</brief_title>
	<detailed_description>Maharishi Vedic Medicine ( MVM ) represent synthesis Vedic science , include Ayur-Veda , single , comprehensive , natural approach health care . The objective phase II pilot trial determine feasibility , acceptability , safety implement multi-modality MVM intervention newly diagnose type 2 diabetic , measure impact protocol overall glycemic control .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Inclusion criterion : Kaiser Permanente member Newly diagnose type 2 Diabetes Baseline glycosylated hemoglobin level 6.07.9 . Exclusion criterion : Pregnancy nurse mother Currently take warfarin Diagnosis psychotic disorder recent hospitalization depression Unable comply attend treatment session</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Diabetes Mellitus Type 2</keyword>
	<keyword>Vedic medicine</keyword>
	<keyword>Ayurveda</keyword>
	<keyword>Transcendental Meditation</keyword>
</DOC>